Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
Acute myeloid leukemia (AML), a common hematological cancer of myeloid lineage cells, generally exhibits poor prognosis in the clinic and demands new treatment options. Recently, direct sequencing of samples from human AMLs and pre-leukemic diseases has unveiled their mutational landscapes and signi...
Main Authors: | Rui Lu, Gang Greg Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00241/full |
Similar Items
-
Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
by: Anthony K. N. Chan, et al.
Published: (2019-05-01) -
MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
by: Doralina do Amaral Rabello, et al.
Published: (2018-02-01) -
Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
by: Bettina Wingelhofer, et al.
Published: (2019-09-01) -
Clinical and biological features of acute myeloid leukemia with MLL gene rearrangements in children and results of therapy according to protocols AML-MM-2000/2006 in the Republic of Belarus
by: Yu. A. Barovskaya, et al.
Published: (2019-01-01) -
Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia
by: Juan José Fung, et al.
Published: (2015-09-01)